ReviewJournal of the Society for Cardiovascular Angiography & Interventions

Bleeding Risk With Antiplatelets and Bruton's Tyrosine Kinase Inhibitors in Patients With Percutaneous Coronary Intervention.

Alan Mendez-Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.